Biomarkers of Insulin Resistance Are Risk Factors for Aortic Stenosis
By Elana Gotkine HealthDay Reporter
MONDAY, Dec. 9, 2024 -- Biomarkers of insulin resistance are risk factors for aortic stenosis (AS), according to a study published online Nov. 27 in the Annals of Medicine.
Maija Sohlman, from the University of Eastern Finland in Kuopio, and colleagues examined biomarkers and the risk for AS in a prospective population-based study involving 10,144 Finnish men without AS at baseline. Variables predicting AS were identified during a follow-up time of 10.8 years. A principal component (PC) analysis was applied to the biomarkers that predicted AS; the resulting PCs were examined as predictors of AS using a Cox regression analysis.
The researchers found that AS was diagnosed in 1.1 percent of men (median age, 62 years). In Cox regression analyses, associations with incident AS were seen for fasting, 30-minute, and 120-minute plasma insulin and proinsulin (hazard ratios ranging from 1.38 to 1.44), the Matsuda index (hazard ratio, 0.68), and serum C-peptide (hazard ratio, 1.47) in addition to age, systolic blood pressure, body mass index, waist circumference, waist/hip ratio, height, body fat mass, fat-free mass, and high sensitivity C-reactive protein. After adjustments or exclusion of individuals with diabetes, these associations remained significant. Significant associations with AS were seen for PC1, which included fasting plasma insulin, C-peptide, the Matsuda index, waist/hip ratio, and urine albumin excretion, and PC2, which consisted of age, body fat mass, and systolic blood pressure (hazard ratios, 1.37 and 1.77, respectively).
"As insulin resistance and hyperinsulinemia appear to be important risk factors for AS, measures improving insulin sensitivity, such as weight control and exercise, might be effective in the prevention of aortic stenosis," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-12-10 06:00
Read more

- More Evidence Ozempic Can Curb Alcoholism
- American Cancer Society Calls for Restoration of Key CDC, FDA Data
- Findings From Pivotal Nipocalimab Phase 3 Study in a Broad Antibody Positive Population of People Living with Generalized Myasthenia Gravis (gMG) Published in The Lancet Neurology
- Benefits of Pediatric Obesity Treatment Endure Into Young Adulthood
- FDA Approves Genentech’s Susvimo as the First and Only Continuous Delivery Treatment for the Treatment of Diabetic Macular Edema
- Few Individuals With Mental, Substance Use Disorders Receive Guideline-Consistent Treatment
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions